Your browser doesn't support javascript.
loading
Alcohol Rehabilitation Within 3 Months After Alcohol Hepatitis and Survival - A National Analysis.
Parlati, Lucia; Mouliade, Charlotte; Khac, Eric Nguyen; Collier, Mathis; Tzedakis, Stylianos; Bouam, Samir; Courtois, Anoisia; Corouge, Marion; Louvet, Alexandre; Pol, Stanislas; Sogni, Philippe; Benyamina, Amine; Rehm, Jürgen; Mathurin, Philippe; Mallet, Vincent.
Affiliation
  • Parlati L; AP-HP.Centre, Groupe Hospitalier Cochin Port Royal, DMU Cancérologie et Spécialités Médico-Chirurgicales, Service de Maladies du Foie, Paris, France; Université Paris Cité, Paris, France.
  • Mouliade C; AP-HP.Centre, Groupe Hospitalier Cochin Port Royal, DMU Cancérologie et Spécialités Médico-Chirurgicales, Service de Maladies du Foie, Paris, France; Université Paris Cité, Paris, France.
  • Khac EN; CHU Amiens, Hôpital sud, Service Hépato-Gastroentérologie, Amiens, France; Université de Picardie Jules Verne, Centre Universitaire de Recherche en Santé, INSERM UMR 1247, Groupe de Recherche sur l'Alcool & les Pharmacodépendances, Amiens, France.
  • Collier M; AP-HP Centre, Groupe Hospitalier Cochin Port Royal, DMU Prime, Unité de Recherche Clinique, Paris, France.
  • Tzedakis S; Université Paris Cité, Paris, France; AP-HP.Centre, Groupe Hospitalier Cochin Port Royal, DMU Cancérologie et Spécialités Médico-Chirurgicales, Service de Chirurgie Digestive, Paris, France.
  • Bouam S; AP-HP.Centre Université de Paris, Groupe Hospitalier Cochin Port Royal, DMU Prime, Service d'Information Médicale, Paris, France.
  • Courtois A; AP-HP.Centre, Groupe Hospitalier Cochin Port Royal, DMU Cancérologie et Spécialités Médico-Chirurgicales, Service de Maladies du Foie, Paris, France.
  • Corouge M; Université de Picardie Jules Verne, Centre Universitaire de Recherche en Santé, INSERM UMR 1247, Groupe de Recherche sur l'Alcool & les Pharmacodépendances, Amiens, France.
  • Louvet A; Service des Maladies de L'appareil Digestif, CHU Lille, Université de Lille and INSERM U995, Lille, France.
  • Pol S; AP-HP.Centre, Groupe Hospitalier Cochin Port Royal, DMU Cancérologie et Spécialités Médico-Chirurgicales, Service de Maladies du Foie, Paris, France; Université Paris Cité, Paris, France.
  • Sogni P; AP-HP.Centre, Groupe Hospitalier Cochin Port Royal, DMU Cancérologie et Spécialités Médico-Chirurgicales, Service de Maladies du Foie, Paris, France; Université Paris Cité, Paris, France.
  • Benyamina A; AP-HP Sud, Hôpital Paul Brousse, Département de Psychiatrie et d'Addictologie, Villejuif, France; Unité de Recherche UR Psychiatrie-Comorbidités-Addictions PSYCOMADD Université Paris Saclay, Paris, France.
  • Rehm J; Institute for Mental Health Policy Research, CAMH, Toronto, Ontario, Canada; Campbell Family Mental Health Research Institute, CAMH, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada; Dalla Lana School of Public Health, University of Toronto, Toronto
  • Mathurin P; Service des Maladies de L'appareil Digestif, CHU Lille, Université de Lille and INSERM U995, Lille, France.
  • Mallet V; AP-HP.Centre, Groupe Hospitalier Cochin Port Royal, DMU Cancérologie et Spécialités Médico-Chirurgicales, Service de Maladies du Foie, Paris, France; Université Paris Cité, Paris, France. Electronic address: vincent.mallet@aphp.fr.
Article in En | MEDLINE | ID: mdl-39209197
ABSTRACT
BACKGROUND &

AIMS:

There is limited understanding of the benefits of alcohol rehabilitation after alcohol hepatitis (AH).

METHODS:

We conducted a 2012 to 2021 national longitudinal study involving adult inpatients diagnosed with AH in France. We assessed the primary outcome of liver transplantation or death within 1 year after AH, including in its complicated form (CAH) defined as ≥2 hepatic or extrahepatic complications within 4 weeks after AH. The primary exposure was in-hospital alcohol rehabilitation within 3 months following AH. Patients who died (6.5%; n = 5282) or were censored (12.5%; n = 10,180) ≤4 weeks after AH were excluded. We measured adjusted hazard ratios (aHRs) and adjusted odds ratios (aORs) within the full cohort and propensity-matched samples.

RESULTS:

Among 65,737 patients (median age, 52 years; interquartile range [IQR], 44-60 years; 76% male), 12% died or underwent liver transplantation. In-hospital alcohol rehabilitation was noted for 25% of patients (15.2% among patients with CAH) and was the primary discharge diagnosis for 13.3%. The 1-year transplant-free survival rates were 94% (95% confidence interval [CI], 94%-95%) for rehabilitated patients, compared with 85% (95% CI, 85%-86%) for those without (aHR, 0.62; 95% CI, 0.57-0.69; P < .001). Among patients with CAH, transplant-free survival was 78% (95% CI, 76%-81%) with rehabilitation vs 70% (95% CI, 69%-71%) without (aHR, 0.82; 95% CI, 0.68-0.98; P = .025). In propensity-matched samples, rehabilitation was linked to an aOR of 0.54 (95% CI, 0.49-0.55; P < .001) overall, and 0.73 (95% CI, 0.60-0.89; P = .002) among matched patients with CAH.

CONCLUSIONS:

In-hospital alcohol rehabilitation within 3 months after AH and CAH improve transplant-free survival rate but remain underutilized.
Key words

Full text: 1 Database: MEDLINE Language: En Year: 2024 Type: Article

Full text: 1 Database: MEDLINE Language: En Year: 2024 Type: Article